Elevance Health (ELV) to Release Earnings on Thursday

Elevance Health (NYSE:ELVGet Free Report) will likely be announcing its earnings results before the market opens on Thursday, January 23rd. Analysts expect the company to announce earnings of $3.80 per share and revenue of $44,633,169.71 billion for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Elevance Health Trading Down 0.3 %

NYSE:ELV opened at $384.26 on Tuesday. Elevance Health has a 12 month low of $362.21 and a 12 month high of $567.26. The business’s 50-day moving average is $388.02 and its two-hundred day moving average is $466.18. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.50 and a quick ratio of 1.50. The firm has a market capitalization of $89.12 billion, a PE ratio of 14.01, a price-to-earnings-growth ratio of 1.08 and a beta of 0.84.

Wall Street Analyst Weigh In

ELV has been the topic of several recent research reports. Raymond James set a $485.00 price target on Elevance Health in a research report on Friday, October 18th. UBS Group decreased their target price on shares of Elevance Health from $605.00 to $555.00 and set a “buy” rating for the company in a research note on Friday, October 18th. Stephens reaffirmed an “underperform” rating on shares of Elevance Health in a research note on Friday, October 18th. TD Cowen cut their price target on Elevance Health from $589.00 to $484.00 and set a “buy” rating on the stock in a research note on Monday, October 21st. Finally, Wells Fargo & Company lowered their price objective on Elevance Health from $593.00 to $495.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $536.53.

Read Our Latest Report on ELV

Elevance Health Company Profile

(Get Free Report)

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

Featured Stories

Earnings History for Elevance Health (NYSE:ELV)

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.